American Society of Clinical Oncology articles over last 30 days

- articles last 30 days - articles per day
Mentioned in this news Places Companies People
2013/05/22 13:50
2013/05/22 13:50
13h
Immune system cancer drugs tipped to be a $35 billion market LONDON (Reuters) - A new wave of medicines that tap the power of the immune system to fight cancer could become the biggest drug class in...
2013/05/22 13:50
2013/05/22 13:50
Latest videos
2013/05/22 13:50
2013/05/22 13:50
Latest from Twitter
2013/05/22 07:09
2013/05/22 07:09
20h
An attack on glioblastoma brain tumor cells that uses a modified poliovirus is showing encouraging results in an early study to establish the proper dose level, researchers at Duke Cancer Institute...
2013/05/21 13:44
2013/05/21 13:44
1d
For more stories, blogs and information on nutrition, fitness, health and advice on how to be healthier, visit columbian.com/livewell. Middle-aged men who stayed fit were less likely to die from...
2013/05/20 04:26
2013/05/20 04:26
2d
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) today announced operating and financial results for the three months ended March 31, 2013, and provided an update on the Company’s...
2013/05/18 22:06
2013/05/18 22:06
4d
Middle-aged men who stayed fit were less likely to die from three common cancers after being diagnosed than those who were out of shape, research found. In a study of 17,049 men, those with good...
2013/05/18 10:27
2013/05/18 10:27
4d
AstraZeneca accelerates cancer drug testing LONDON (Reuters) - AstraZeneca has enrolled the first patient into a final-stage clinical trial of a new drug for a rare type of leukemia as the group's...
2013/05/17 19:06
2013/05/17 19:06
5d
Puma Biotechnology Inc. (PBYI), the maker of an experimental cancer drug, rose the most in seven months in intraday trading after data on a competitor medicine did nothing to diminish analysts’...
2013/05/17 16:13
2013/05/17 16:13
5d
THURSDAY, May 16 (HealthDay News) -- Men who are physically fit in middle age have a lower risk of developing and dying from certain cancers, new research indicates. "Fitness is a huge predictor of...
2013/05/17 15:22
2013/05/17 15:22
5d
NEW YORK (TheStreet) -- TheStreet's senior columnist Adam Feuerstein and Gregg Greenberg talked about the research abstracts ahead of the American Society of Clinical Oncology event later this...
2013/05/17 14:48
2013/05/17 14:48
5d
By Brenda GoodmanHealthDay Reporter THURSDAY, May 16 (HealthDay News) -- An experimental drug that taps the power of the body's immune system to fight cancer is shrinking tumors in patients for whom...
2013/05/17 12:57
2013/05/17 12:57
5d
NEW YORK, NY--(Marketwired - May 17, 2013) - The Bedford Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Bedford is an essential...
2013/05/17 07:17
2013/05/17 07:17
5d
FOSTER CITY, Californie--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq : GILD) a annoncé aujourd'hui les résultats d'une étude de phase 2 (l'étude 101-08) évaluant l'Idelalisib (anciennement...
2013/05/17 07:08
2013/05/17 07:08
5d
Most cancer patients would like to talk about the cost of their care with their doctors, but often don't because they fear the discussion could compromise the quality of their treatment, researchers...
2013/05/17 04:17
2013/05/17 04:17
5d
FOSTER CITY, Californië (VS)--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) heeft vandaag de resultaten bekend gemaakt van een fase 2-studie (studie 101-08) die idelalisib evalueert (voorheen...
2013/05/16 15:06
2013/05/16 15:06
6d
Less cancer treatment may be better, and being in good physical shape may help keep cancer away, according to the latest research being presented at the largest convergence of cancer experts...
2013/05/16 12:09
2013/05/16 12:09
6d
New findings validate clinical utility in Colorectal Cancer Staging DiagnoCure Inc. (TSX: CUR) (OTCQX: DGCRF) (the "Corporation"), today announced that results from a large validation study of the...
2013/05/16 10:08
2013/05/16 10:08
6d
The majority of cancer doctors, patients, and members of the general public support cutting health care costs by refusing to pay for drugs that don't improve survival or quality of life, according to...
2013/05/16 09:08
2013/05/16 09:08
6d
Bayer HealthCare announced today that new data on the oncology portfolio, including Nexavar® (sorafenib) tablets, Stivarga® (regorafenib) tablets and the recently U.S. Food and Drug Administration...
2013/05/16 07:17
2013/05/16 07:17
6d
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced results from a Phase 2 study (Study 101-08) evaluating idelalisib (formerly GS-1101), an investigational,...
2013/05/16 06:57
2013/05/16 06:57
6d
LUND, SWEDEN--(Marketwired - May 16, 2013) - Active Biotech (NASDAQ OMX NORDIC: ACTI) will present data from two of its oncology projects, the drug candidates tasquinimod for the treatment of prostate...